Cardiovascular Morbidity in COPD: A Study of the General Population

ABSTRACT Although there are a number of studies on the coexistence of heart disease and COPD among patients acutely admitted to hospital, this relationship has not been accurately described in the general population. Especially data on the prevalence of both reduced lung function and impaired left ventricular ejection fraction (LVEF) are sparse. We used data from the 4th examination of The Copenhagen City Heart Study, which comprises 5,890 individuals with data on pulmonary and cardiac symptoms, risk factors for cardiovascular diseases, pulmonary function tests, ECG and relevant medical history. Among the participants a randomly selected subgroup of 3,469 individuals underwent both spirometry and echocardiography. The participants were classified according to COPD stage using the international GOLD staging according to FEV1 in %% of predicted. The prevalence of COPD was 5.7%% for mild COPD (GOLD stage 1), 9.4%% for moderate COPD (GOLD stage 2) and 2.5%% for severe and very severe COPD (GOLD stages 3++4). Individuals with COPD were older and had a higher prevalence of cardiovascular risk factors and a higher prevalence of cardiovascular diseases. Among the echocardiographical findings, only the presence of left ventricular hyperthrophy was significantly more frequent among individuals with COPD (17.7%%) than among participants without COPD (12.1%%.), yet this relationship was no longer significant after statistical adjustment for age and gender. In the general population, subjects with COPD have a higher prevalence of cardiovascular diseases and an unfavourable cardiovascular risk profile compared with individuals without COPD, but this was mainly related to higher age among the participants with COPD.

[1]  C. Torp‐Pedersen,et al.  Chronic obstructive pulmonary disease in patients admitted with heart failure , 2008, Journal of internal medicine.

[2]  T. Omland,et al.  Underdiagnosis of myocardial infarction in COPD - Cardiac Infarction Injury Score (CIIS) in patients hospitalised for COPD exacerbation. , 2008, Respiratory medicine.

[3]  T. LeJemtel,et al.  Coexistent chronic obstructive pulmonary disease and heart failure in the elderly. , 2008, International journal of cardiology.

[4]  D. Mannino,et al.  Relationship between lung function impairment and incidence or recurrence of cardiovascular events in a middle-aged cohort , 2008, Thorax.

[5]  W. MacNee,et al.  Cardiovascular risk in chronic obstructive pulmonary disease , 2007, Respirology.

[6]  Judith K Jones,et al.  Cardiovascular disease in patients with chronic obstructive pulmonary disease, Saskatchewan Canada cardiovascular disease in COPD patients. , 2006, Annals of epidemiology.

[7]  S. Sidney,et al.  COPD and incident cardiovascular disease hospitalizations and mortality: Kaiser Permanente Medical Care Program. , 2005, Chest.

[8]  K. Davis,et al.  Trends and Cardiovascular Co-morbidities of COPD Patients in the Veterans Administration Medical System, 1991–1999 , 2005, COPD.

[9]  F. Rutten,et al.  Unrecognized heart failure in elderly patients with stable chronic obstructive pulmonary disease. , 2005, European heart journal.

[10]  R. Pauwels,et al.  Burden and clinical features of chronic obstructive pulmonary disease (COPD) , 2004, The Lancet.

[11]  D. Levy,et al.  Plasma natriuretic peptide levels and the risk of cardiovascular events and death , 2004 .

[12]  W. MacNee,et al.  Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper , 2004, European Respiratory Journal.

[13]  S. Lareau,et al.  Descriptors of dyspnea by patients with chronic obstructive pulmonary disease versus congestive heart failure. , 2004, Heart & lung : the journal of critical care.

[14]  D. Sin,et al.  Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases? The potential role of systemic inflammation in chronic obstructive pulmonary disease. , 2003, Circulation.

[15]  J. Rehfeld,et al.  Quantification of pro-B-type natriuretic peptide and its products in human plasma by use of an analysis independent of precursor processing. , 2002, Clinical Chemistry.

[16]  R. Pauwels,et al.  Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. , 2001, American journal of respiratory and critical care medicine.

[17]  S. Neubauer,et al.  Alterations in myocardial creatinine kinase (CK) and lactate dehydrogenase (LDH) isoenzyme‐distribution in a model of left ventricular dysfunction , 2001, European journal of heart failure.

[18]  P. Schnohr The Copenhagen City Heart Study : Østerbroundersøgelsen : tables with data from the third examination 1991-1994 , 2001 .

[19]  E. Trulock,et al.  Right and left ventricular dysfunction in patients with severe pulmonary disease. , 1998, Chest.

[20]  Alan D. Lopez,et al.  Alternative projections of mortality and disability by cause 1990–2020: Global Burden of Disease Study , 1997, The Lancet.

[21]  V M Hawthorne,et al.  Impaired lung function and mortality risk in men and women: findings from the Renfrew and Paisley prospective population study , 1996, BMJ.

[22]  D. Levy,et al.  Comparison of enalapril versus nifedipine to decrease left ventricular hypertrophy in systemic hypertension (the PRESERVE trial). , 1996, The American journal of cardiology.

[23]  P. Lange Development and prognosis of chronic obstructive pulmonary disease with special reference to the role of tobacco smoking. An epidemiologic study. , 1992, Danish medical bulletin.

[24]  P. Schnohr,et al.  Ventilatory function impairment and risk of cardiovascular death and of fatal or non-fatal myocardial infarction. , 1991, The European respiratory journal.

[25]  N. Reichek,et al.  Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. , 1989, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[26]  The Copenhagen City Heart Study. Osterbroundersøgelsen. A book of tables with data from the first examination (1976-78) and a five year follow-up (1981-83). The Copenhagen City Heart Study Group. , 1989, Scandinavian journal of social medicine. Supplementum.

[27]  N. Reichek,et al.  Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. , 1986, The American journal of cardiology.

[28]  A. Siegelaub,et al.  Lung function and risk of myocardial infarction and sudden cardiac death. , 1976, The New England journal of medicine.

[29]  H. Blackburn,et al.  Cardiovascular survey methods. , 1969, East African medical journal.

[30]  C. H. Wood,et al.  Significance of Respiratory Symptoms and the Diagnosis of Chronic Bronchitis in a Working Population , 1959, British medical journal.

[31]  D. DuBois,et al.  A formula to estimate the approximate surface area if height and weight be known , 1989 .

[32]  D. D. Bois,et al.  CLINICAL CALORIMETRY: TENTH PAPER A FORMULA TO ESTIMATE THE APPROXIMATE SURFACE AREA IF HEIGHT AND WEIGHT BE KNOWN , 1916 .